{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:57:37Z","timestamp":1792083457565,"version":"4.4.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bioactmat.2026.07.009","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:48:27Z","timestamp":1783705707000},"page":"469-486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Single-cell and longitudinal transcriptomics-guided engineering of FZD1-targeting precision nanotherapy against osteosarcoma cancer stem cells"],"prefix":"10.1016","volume":"66","author":[{"given":"Zhiyu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1052-1710","authenticated-orcid":false,"given":"Wanli","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunsheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaochu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0984-2947","authenticated-orcid":false,"given":"Jianxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengxue","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioactmat.2026.07.009_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41572-022-00409-y","article-title":"Osteosarcoma","volume":"8","author":"Beird","year":"2022","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bioactmat.2026.07.009_bib2","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra2103423","article-title":"New horizons in the treatment of osteosarcoma","volume":"385","author":"Meltzer","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib3","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1158\/1078-0432.CCR-14-1429","article-title":"Translational implications of tumor heterogeneity","volume":"21","author":"Jamal-Hanjani","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccell.2020.03.007","article-title":"Intratumor heterogeneity: the rosetta stone of therapy resistance","volume":"37","author":"Marusyk","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioactmat.2026.07.009_bib5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41571-021-00519-8","article-title":"Advancing therapy for osteosarcoma","volume":"18","author":"Gill","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib6","doi-asserted-by":"crossref","first-page":"8940","DOI":"10.1038\/ncomms9940","article-title":"Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency","volume":"6","author":"Kovac","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.canlet.2016.11.019","article-title":"Cancer stem cells in osteosarcoma","volume":"386","author":"Brown","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib8","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.canlet.2015.11.013","article-title":"Chemotherapy induces stemness in osteosarcoma cells through activation of Wnt\/\u03b2-catenin signaling","volume":"370","author":"Martins-Neves","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/onc.2016.194","article-title":"MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1","volume":"36","author":"Lu","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bioactmat.2026.07.009_bib10","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMra1804280","article-title":"Clinical and therapeutic implications of cancer stem cells","volume":"380","author":"Clarke","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrc3184","article-title":"Cancer stem cells: an evolving concept","volume":"12","author":"Nguyen","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioactmat.2026.07.009_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","article-title":"Targeting cancer stem cell pathways for cancer therapy","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib13","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","article-title":"Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer","volume":"171","author":"Puram","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bioactmat.2026.07.009_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/science.aai8478","article-title":"Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq","volume":"355","author":"Venteicher","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bioactmat.2026.07.009_bib15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41392-020-00248-x","article-title":"Nanoparticle enhanced combination therapy for stem-like progenitors defined by single-cell transcriptomics in chemotherapy-resistant osteosarcoma","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib16","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1038\/s41467-020-20059-6","article-title":"Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41413-022-00237-6","article-title":"Characterizing the tumor microenvironment at the single-cell level reveals a novel immune evasion mechanism in osteosarcoma","volume":"11","author":"Liu","year":"2023","journal-title":"Bone Res."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41413-022-00233-w","article-title":"A novel molecular classification method for osteosarcoma based on tumor cell differentiation trajectories","volume":"11","author":"Zhang","year":"2023","journal-title":"Bone Res."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib19","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.7150\/thno.73714","article-title":"Single-cell transcriptomics reveals the regulative roles of cancer associated fibroblasts in tumor immune microenvironment of recurrent osteosarcoma","volume":"12","author":"Huang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.bioactmat.2026.07.009_bib20","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bioactmat.2026.07.009_bib21","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bioactmat.2026.07.009_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13046-024-02947-7","article-title":"The dopamine receptor D1 inhibitor, SKF83566, suppresses GBM stemness and invasion through the DRD1-c-Myc-UHRF1 interactions","volume":"43","author":"Xue","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib23","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIRCULATIONAHA.122.061940","article-title":"SOX17 enhancer variants disrupt transcription factor binding and enhancer inactivity drives pulmonary hypertension","volume":"147","author":"Walters","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.bioactmat.2026.07.009_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn2110","article-title":"A systems approach points to a therapeutic role for retinoids in asparaginase-associated pancreatitis","volume":"15","author":"Tsai","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib25","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamapsychiatry.2023.1808","article-title":"Transcriptome-wide structural equation modeling of 13 major psychiatric disorders for cross-disorder risk and drug repurposing","volume":"80","author":"Grotzinger","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.bioactmat.2026.07.009_bib26","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.devcel.2024.01.019","article-title":"Wnt dose escalation during the exit from pluripotency identifies tranilast as a regulator of cardiac mesoderm","volume":"59","author":"Wu","year":"2024","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bioactmat.2026.07.009_bib27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41565-020-00793-0","article-title":"A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells","volume":"16","author":"Shen","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib28","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41551-024-01178-7","article-title":"Severely polarized extracellular acidity around tumour cells","volume":"8","author":"Feng","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202312169","article-title":"Nanomedicine tumor targeting","volume":"36","author":"Lammers","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41568-020-0263-0","article-title":"The dormant cancer cell life cycle","volume":"20","author":"Phan","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioactmat.2026.07.009_bib31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13018-016-0487-6","article-title":"Verification of TREX1 as a promising indicator of judging the prognosis of osteosarcoma","volume":"11","author":"Feng","year":"2016","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib32","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.stem.2024.04.004","article-title":"Hallmarks of cancer stemness","volume":"31","author":"Loh","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bioactmat.2026.07.009_bib33","first-page":"2537","article-title":"Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells","volume":"10","author":"Ni","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib34","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1038\/ncomms7411","article-title":"Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells","volume":"6","author":"Basu-Roy","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib35","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12929-016-0297-5","article-title":"Defective autophagy leads to the suppression of stem-like features of CD271(+) osteosarcoma cells","volume":"23","author":"Zhang","year":"2016","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib36","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1038\/s41388-018-0292-2","article-title":"Sox2 is required for tumor development and cancer cell proliferation in osteosarcoma","volume":"37","author":"Maurizi","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.bioactmat.2026.07.009_bib37","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1101\/gad.891401","article-title":"Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin","volume":"15","author":"Merrill","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib38","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.1158\/0008-5472.CAN-12-0119","article-title":"Control of breast cancer growth and initiation by the stem cell-associated transcription factor TCF3","volume":"72","author":"Slyper","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib39","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","article-title":"Nanomedicine in cancer therapy","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib40","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","article-title":"Machine learning identifies stemness features associated with oncogenic dedifferentiation","volume":"173","author":"Malta","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bioactmat.2026.07.009_bib41","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/s41422-020-0370-1","article-title":"Wnt signaling and Loxl2 promote aggressive osteosarcoma","volume":"30","author":"Matsuoka","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib42","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.tips.2007.09.001","article-title":"The frizzled family of unconventional G-protein-coupled receptors","volume":"28","author":"Schulte","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib43","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.110.976969","article-title":"Blocking of frizzled signaling with a homologous peptide fragment of wnt3a\/wnt5a reduces infarct expansion and prevents the development of heart failure after myocardial infarction","volume":"124","author":"Laeremans","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.bioactmat.2026.07.009_bib44","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1016\/j.neuron.2021.07.018","article-title":"Oligodendroglial ring finger protein Rnf43 is an essential injury-specific regulator of oligodendrocyte maturation","volume":"109","author":"Niu","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.bioactmat.2026.07.009_bib45","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1038\/onc.2009.80","article-title":"The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt\/beta-catenin pathway","volume":"28","author":"Flahaut","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.bioactmat.2026.07.009_bib46","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.canlet.2012.03.039","article-title":"Interference of Frizzled 1 (FZD1) reverses multidrug resistance in breast cancer cells through the Wnt\/\u03b2-catenin pathway","volume":"323","author":"Zhang","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib47","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1158\/0008-5472.CAN-20-2876","article-title":"Hypoxia-induced suppression of alternative splicing of MBD2 promotes breast cancer metastasis via activation of FZD1","volume":"81","author":"Liu","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41375-019-0513-x","article-title":"Oxidative stress as candidate therapeutic target to overcome microenvironmental protection of CLL","volume":"34","author":"Yosifov","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.bioactmat.2026.07.009_bib49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/neuonc\/noad155","article-title":"Sirtuin 2 inhibition modulates chromatin landscapes genome-wide to induce senescence in ATRX-deficient malignant glioma","volume":"26","author":"Malgulwar","year":"2024","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00535-023-02052-0","article-title":"Lansoprazole inhibits the development of sessile serrated lesions by inducing G1 arrest via Skp2\/p27 signaling pathway","volume":"59","author":"Kawaguchi","year":"2024","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib51","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1039\/c2np20037f","article-title":"Natural products from Cephalotaxus sp.: chemical diversity and synthetic aspects","volume":"29","author":"Abdelkafi","year":"2012","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib52","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1158\/1078-0432.CCR-13-1283","article-title":"Omacetaxine: a protein translation inhibitor for treatment of chronic myelogenous leukemia","volume":"20","author":"Gandhi","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib53","first-page":"205","article-title":"Chapter four - cephalotaxus alkaloids, Alkaloids","volume":"78","author":"P\u00e9rard-Viret","year":"2017","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib54","article-title":"Homoharringtonine: mechanisms, clinical applications and research progress","volume":"15","author":"Wang","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib55","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.addr.2020.06.005","article-title":"Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers","volume":"157","author":"Fang","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib56","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib57","doi-asserted-by":"crossref","first-page":"9123","DOI":"10.3390\/ijms21239123","article-title":"Aptamer-functionalized nanoparticles in targeted delivery and cancer therapy","volume":"21","author":"Fu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201606628","article-title":"Rational design of cancer nanomedicine: nanoproperty integration and synchronization","volume":"29","author":"Sun","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202000055","article-title":"Designing stimuli-responsive upconversion nanoparticles that exploit the tumor microenvironment","volume":"32","author":"Ovais","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib60","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1158\/0008-5472.CAN-20-0617","article-title":"Dysregulated glutamate transporter SLC1A1 propels cystine uptake via Xc(-) for glutathione synthesis in lung cancer","volume":"81","author":"Guo","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib61","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature07733","article-title":"Association of reactive oxygen species levels and radioresistance in cancer stem cells","volume":"458","author":"Diehn","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bioactmat.2026.07.009_bib62","article-title":"Synergistic chemo-immunotherapy for osteosarcoma via a pH-responsive multi-component nanoparticle system","volume":"16","author":"Li","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioactmat.2026.07.009_bib63","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12943-024-02105-9","article-title":"Advances on immunotherapy for osteosarcoma","volume":"23","author":"Yu","year":"2024","journal-title":"Mol. Cancer"}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X2600397X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X2600397X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:19:59Z","timestamp":1792081199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X2600397X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":63,"alternative-id":["S2452199X2600397X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.07.009","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-cell and longitudinal transcriptomics-guided engineering of FZD1-targeting precision nanotherapy against osteosarcoma cancer stem cells","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}